Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: The American Journal of Cardiology

Abbreviated Title: The American Journal of Cardiology

Publisher: Elsevier BV

ISSN (Print): 00029149

Publication date Created: June 1999

Publication date (Print): June 1999

Volume: 83

Issue: 12

Pages: 21-25

Article

DOI: 10.1016/S0002-9149(99)00314-8

SO-VID: a4afd5e6-5305-4d64-9396-95f3fca26c7b

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_